Stay updated on Evinacumab in Pediatric Homozygous FH Clinical Trial
Sign up to get notified when there's something new on the Evinacumab in Pediatric Homozygous FH Clinical Trial page.

Latest updates to the Evinacumab in Pediatric Homozygous FH Clinical Trial page
- Check3 days agoChange DetectedNew revision entry Revision: v3.3.4 was added to the Record History, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new Revision: v3.3.3 is added and the HHS Vulnerability Disclosure entry is removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check53 days agoChange DetectedThe Record History shows a new revision entry (v3.3.2) and removal of an older revision (v3.2.0), indicating an update to the page's version history.SummaryDifference0.1%

- Check60 days agoChange DetectedDeleted the site-wide notice about government funding and NIH operating status.SummaryDifference0.7%

- Check74 days agoChange DetectedThe new version updates the study status and recruitment status. Contacts/Locations details were revised to reflect the current state of the trial.SummaryDifference0.1%

- Check103 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference11%

Stay in the know with updates to Evinacumab in Pediatric Homozygous FH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Evinacumab in Pediatric Homozygous FH Clinical Trial page.